• Info
  • Insider Ownership

Insider Trading & Ownership of Mathai Mammen

Location
South San Francisco, CA
Summary
The estimated net worth of Mathai Mammen is at least $15.1M dollars as of 13 Jun 2024. Mathai Mammen is the EVP, Pharm, R&D of JOHNSON & JOHNSON and owns shares of JOHNSON & JOHNSON (JNJ) stock worth about $10.8M. Mathai Mammen is the Director of 10x Genomics, Inc. and owns shares of 10x Genomics, Inc. (TXG) stock worth about $4.38M.
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Mathai Mammen
All Insider Reports
All Insider Reports

Notify me when Mathai Mammen files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mathai Mammen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JNJ JOHNSON & JOHNSON EVP, Pharm, R&D $10.8M 14 Feb 2022
TXG 10x Genomics, Inc. Director $4.38M 11 Jun 2024

Insider Transactions Reported by Mathai Mammen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.